Cargando…

Efficacy of Moderate Intensity Statins in the Treatment of Dyslipidemia in Korean Patients with Type 2 Diabetes Mellitus

BACKGROUND: There has been evidences of ethnic differences in the low density lipoprotein cholesterol (LDL-C) lowering effect of statin. We aimed to evaluate the efficacy of moderate-intensity statins in the treatment of dyslipidemia among Korean patients with type 2 diabetes mellitus (T2DM). METHOD...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kong, Sung Hye, Koo, Bo Kyung, Moon, Min Kyong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Korean Diabetes Association 2017
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5328693/ https://www.ncbi.nlm.nih.gov/pubmed/28029012 http://dx.doi.org/10.4093/dmj.2017.41.1.23

Ejemplares similares

Response: Efficacy of Moderate Intensity Statins in the Treatment of Dyslipidemia in Korean Patients with Type 2 Diabetes Mellitus (Diabetes Metab J 2017;41:23-30)
por: Kong, Sung Hye, et al.
Publicado: (2017)

Letter: Efficacy of Moderate Intensity Statins in the Treatment of Dyslipidemia in Korean Patients with Type 2 Diabetes Mellitus (Diabetes Metab J 2017;41:23-30)
por: Jeon, Jae-Han
Publicado: (2017)

Re-Evaluation of Efficacy of Moderate-Intensity Statins in Korean Patients with Type 2 Diabetes Mellitus
por: Kim, Soo Kyoung
Publicado: (2017)

Are We in the Same Risk of Diabetes Mellitus? Gender- and Age-Specific Epidemiology of Diabetes in 2001 to 2014 in the Korean Population
por: Koo, Bo Kyung, et al.
Publicado: (2016)

Effects of Dapagliflozin on Endothelial Function, Renal Injury Markers, and Glycemic Control in Drug-Naïve Patients with Type 2 Diabetes Mellitus
por: Kong, Sung Hye, et al.
Publicado: (2019)

Response: Effects of Dapagliflozin on Endothelial Function, Renal Injury Markers, and Glycemic Control in Drug-Naïve Patients with Type 2 Diabetes Mellitus (Diabetes Metab J 2019:43:711–7)
por: Kong, Sung Hye, et al.
Publicado: (2019)

Assessment of Diabetic Polyneuropathy and Autonomic Neuropathy Using Current Perception Threshold in Korean Patients with Diabetes Mellitus
por: Koo, Bo Kyung, et al.
Publicado: (2014)

Efficacy and Safety of High-Dose Atorvastatin in Moderate-to-High Cardiovascular Risk Postmenopausal Korean Women with Dyslipidemia
por: Moon, Jaecheol, et al.
Publicado: (2020)

Efficacy and Safety of Sodium-Glucose Cotransporter-2 Inhibitors in Korean Patients with Type 2 Diabetes Mellitus in Real-World Clinical Practice
por: Hong, A Ram, et al.
Publicado: (2019)

Statin for the Primary Prevention of Cardiovascular Disease in Patients with Diabetes Mellitus
por: Koo, Bo Kyung
Publicado: (2014)

Phenotyping of Korean patients with better-than-expected efficacy of moderate-intensity statins using tensor factorization
por: Choi, Jingyun, et al.
Publicado: (2018)

Low Economic Status Is Identified as an Emerging Risk Factor for Diabetes Mellitus in Korean Men Aged 30 to 59 Years in Korean National Health and Nutrition Examination Survey 2008 to 2010
por: Koo, Bo Kyung, et al.
Publicado: (2015)

Effect of Atorvastatin on Growth Differentiation Factor-15 in Patients with Type 2 Diabetes Mellitus and Dyslipidemia
por: Kim, Ji Min, et al.
Publicado: (2016)

Moderate- to high-intensity statins for secondary prevention in patients with type 2 diabetes mellitus on dialysis after acute myocardial infarction
por: Li, Yan-Rong, et al.
Publicado: (2017)

New Drugs for Treating Dyslipidemia: Beyond Statins
por: Ahn, Chang Ho, et al.
Publicado: (2015)

Thrombin Generation Assay Detects Moderate-Intensity Statin-Induced Reduction of Hypercoagulability in Diabetes
por: Park, Hee Sue, et al.
Publicado: (2018)

New onset diabetes mellitus and cardiovascular events in Korean patients with acute myocardial infarction receiving high-intensity statins
por: Choi, Jah Yeon, et al.
Publicado: (2021)

Comparison of efficacy and safety of combination therapy with statins and omega-3 fatty acids versus statin monotherapy in patients with dyslipidemia: A systematic review and meta-analysis
por: Choi, Hye Duck, et al.
Publicado: (2018)

Decreasing Trends of the Prevalence of Diabetes and Obesity in Korean Women Aged 30–59 Years Over the Past Decade: Results From the Korean National Health and Nutrition Examination Survey, 2001–2010
por: Koo, Bo Kyung, et al.
Publicado: (2013)

Lipid Management in Korean People With Type 2 Diabetes Mellitus: Korean Diabetes Association and Korean Society of Lipid and Atherosclerosis Consensus Statement
por: Yang, Ye Seul, et al.
Publicado: (2023)

Lipid Management in Korean People with Type 2 Diabetes Mellitus: Korean Diabetes Association and Korean Society of Lipid and Atherosclerosis Consensus Statement
por: Yang, Ye Seul, et al.
Publicado: (2023)

Comparative safety and efficacy of low- or moderate-intensity statin plus ezetimibe combination therapy and high-intensity statin monotherapy: A meta-analysis of randomized controlled studies
por: Ah, Young-Mi, et al.
Publicado: (2022)

Letter: Prevalence of Dyslipidemia among Korean Adults: Korea National Health and Nutrition Survey 1998-2005 (Diabetes Metab J 2012;36:43-55)
por: Koo, Bo Kyung
Publicado: (2012)

Association of Handgrip Strength with Diabetes Mellitus in Korean Adults According to Sex
por: Lee, Sung-Bum, et al.
Publicado: (2022)

A Genome-Wide Association Study of Gestational Diabetes Mellitus in Korean Women
por: Kwak, Soo Heon, et al.
Publicado: (2012)

Difference between old and young adults in contribution of β‐cell function and sarcopenia in developing diabetes mellitus
por: Koo, Bo Kyung, et al.
Publicado: (2015)

The role of dyslipidemia and statins in venous thromboembolism
por: Ray, Joel G, et al.
Publicado: (2001)

Post-Diagnostic Statin Use Reduces Mortality in South Korean Patients with Dyslipidemia and Gastrointestinal Cancer
por: Han, Kyu-Tae, et al.
Publicado: (2021)

Impact of metformin on statin‐associated myopathy risks in dyslipidemia patients
por: Bak, Keunhyeong, et al.
Publicado: (2023)

Efficacy of Sitagliptin When Added to Ongoing Therapy in Korean Subjects with Type 2 Diabetes Mellitus
por: Chung, Hye Soo, et al.
Publicado: (2011)

Effect of moderate-intensity statin with ezetimibe combination vs. high-intensity statin therapy according to sex in patients with atherosclerosis
por: Kim, Byung Gyu, et al.
Publicado: (2023)

Non-fasting triglyceride levels in the Korean population with and without ischemic heart disease and cerebrovascular disease
por: Lee, Seo Young, et al.
Publicado: (2019)

Association Between the Awareness of Dyslipidemia and Health Behavior for Control of Lipid Levels Among Korean Adults with Dyslipidemia
por: Cho, In Young, et al.
Publicado: (2017)

Impacts of statin and metformin on neuropathy in patients with type 2 diabetes mellitus: Korean Health Insurance data
por: Min, Hong Ki, et al.
Publicado: (2021)

Dyslipidemia in Pediatric Type 2 Diabetes Mellitus
por: Sunil, Bhuvana, et al.
Publicado: (2020)

Association between Heavy Metal Exposure and Dyslipidemia among Korean Adults: From the Korean National Environmental Health Survey, 2015–2017
por: Kim, Do-won, et al.
Publicado: (2022)

Short Stature is Associated with Increased Risk of Dyslipidemia in Korean Adolescents and Adults
por: Oh, Na-Kyung, et al.
Publicado: (2019)

Association between muscle strength and advanced fibrosis in non‐alcoholic fatty liver disease: a Korean nationwide survey
por: Kang, Sunyoung, et al.
Publicado: (2020)

Screening for Prediabetes and Diabetes in Korean Nonpregnant Adults: A Position Statement of the Korean Diabetes Association, 2022
por: Lee, Kyung Ae, et al.
Publicado: (2022)

Prevalence and types of persistent dyslipidemia in patients treated with statins
por: Reiner, Željko, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_o7n2mladcpleacc4bh1u6b19l2